Brighton Jones’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-20,491
Closed -$34.4K – 1492
2026
Q2
$34.4K Buy
20,491
+6,485
+46% +$9.43K ﹤0.01% 1382
2026
Q1
$18.5K Buy
+14,006
New +$25.1K ﹤0.01% 1188

Other funds holding PACB

Brighton Jones's PACB Position: Q3 2026 in Review

Brighton Jones sold out of Pacific Biosciences (PACB) in Q3 2026, closing a stake of 20,491 shares — an estimated $34.4K sold.

Brighton Jones first reported a position in PACB in Q1 2026 and held it in 2 quarters. The position peaked at $34.4K in Q2 2026. 160 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

  • Brighton Jones reported no remaining Pacific Biosciences position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 20,491 Pacific Biosciences shares in Q3 2026, an estimated $34.4K.
  • Brighton Jones first reported a position in Pacific Biosciences in Q1 2026 and held it in 2 quarters.
  • Brighton Jones's Pacific Biosciences position peaked at $34.4K in Q2 2026.
  • 160 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.